Pages that link to "Q44110680"
Jump to navigation
Jump to search
The following pages link to Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma (Q44110680):
Displaying 50 items.
- Barrett's oesophagus and adenocarcinoma (Q24791935) (← links)
- CagA-positive Helicobacter pylori infection is not associated with decreased risk of Barrett's esophagus in a population with high H. pylori infection rate (Q25257847) (← links)
- Barrett's esophagus in 2016: From pathophysiology to treatment (Q26751171) (← links)
- Epidemiology of Barrett's Esophagus and Esophageal Adenocarcinoma (Q26825742) (← links)
- Risk factors for neoplastic progression in Barrett’s esophagus (Q27002062) (← links)
- Endoscopic risk factors for neoplastic progression in patients with Barrett's oesophagus (Q28079946) (← links)
- Environmental causes of esophageal cancer (Q28388848) (← links)
- Secular trends in patients diagnosed with Barrett's esophagus (Q30484275) (← links)
- A segregation analysis of Barrett's esophagus and associated adenocarcinomas. (Q30493653) (← links)
- Barrett esophagus: ablative methods of treatment (Q31137477) (← links)
- Visible endoscopic and histologic changes in the cardia, before and after complete Barrett's esophagus ablation (Q33213779) (← links)
- Incidence and predictors of adenocarcinoma following endoscopic ablation of Barrett's esophagus. (Q33807282) (← links)
- Short segment hiatal hernia: is it a clinically significant entity? (Q33890445) (← links)
- Mosapride as an adjunct to lansoprazole for symptom relief of reflux oesophagitis (Q34026230) (← links)
- Dietary fiber and the risk of precancerous lesions and cancer of the esophagus: a systematic review and meta-analysis. (Q34354632) (← links)
- Barrett's oesophagus: epidemiology, cancer risk and implications for management (Q34375216) (← links)
- British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus (Q34380645) (← links)
- Prevalence and Risk Factors for Barrett's Esophagus in Patients with GERD in Northern India; Do Methylene Blue-directed Biopsies Improve Detection of Barrett's Esophagus Compared the Conventional Method? (Q34401458) (← links)
- Epidemiologic risk factors for Barrett's esophagus and associated adenocarcinoma (Q34554095) (← links)
- Barrett's esophagus and Barrett's carcinoma (Q35095361) (← links)
- Elevated serum gastrin is associated with a history of advanced neoplasia in Barrett's esophagus (Q35116562) (← links)
- Review article: indications for anti-reflux surgery in gastro-oesophageal reflux disease (Q35145041) (← links)
- Mechanisms of Barrett's oesophagus (clinical): LOS dysfunction, hiatal hernia, peristaltic defects. (Q35162477) (← links)
- Clinical Significance of Hiatal Hernia (Q35195425) (← links)
- The Epidemiology of Gastroesophageal Reflux Disease (Q35582820) (← links)
- The homeodomain protein CDX2 is an early marker of Barrett's oesophagus. (Q35588064) (← links)
- Surgical therapies in Barrett's esophagus (Q35589393) (← links)
- Risk factors affecting the Barrett's metaplasia-dysplasia-neoplasia sequence (Q35622201) (← links)
- Predictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett's Esophagus (Q35666515) (← links)
- Acid inhibitory medication and risk of gastric and oesophageal cancer (Q35769164) (← links)
- The role of the hiatus hernia in gastro-oesophageal reflux disease (Q35893207) (← links)
- Review article: trials on reflux disease -- the role of acid secretion and inhibition (Q35904891) (← links)
- Validation of the Prague C & M criteria for the endoscopic grading of Barrett's esophagus by gastroenterology trainees: a multicenter study (Q35991301) (← links)
- Patient reported outcomes in gastroesophageal reflux disease: an overview of available measures (Q36079695) (← links)
- Barrett esophagus: perspectives on its diagnosis and management in asian populations. (Q36088835) (← links)
- Predictors of progression in Barrett's esophagus: current knowledge and future directions (Q36127891) (← links)
- Association Between Alcohol Consumption and the Risk of Barrett's Esophagus: A Meta-Analysis of Observational Studies (Q36195207) (← links)
- Characteristics of patients with columnar-lined Barrett's esophagus and risk factors for progression to esophageal adenocarcinoma (Q36496675) (← links)
- Surgical management of esophagogastric junction tumors (Q36640053) (← links)
- Risk of Malignant Progression in Barrett's Esophagus Patients: Results from a Large Population-Based Study (Q36783294) (← links)
- Columnar-lined Esophagus: Its Prevalence and Predictors in Patients With Gastroesophageal Reflux Disease (Am J Gastroenterol 2012;107:1655-1661). (Q36817431) (← links)
- Prevalence of Barrett's esophagus in Northern Greece: A Prospective Study (Barrett's esophagus). (Q37082374) (← links)
- Canadian consensus on medically acceptable wait times for digestive health care (Q37138395) (← links)
- Management of high-grade dysplasia. (Q37215492) (← links)
- MicroRNA expression signatures in Barrett's esophagus and esophageal adenocarcinoma (Q37350288) (← links)
- Temporal and spatial evolution of somatic chromosomal alterations: a case-cohort study of Barrett's esophagus (Q37524048) (← links)
- Managing Barrett's esophagus with radiofrequency ablation (Q37609156) (← links)
- Short-Segment Barrett's Esophagus and Adenocarcinoma (Q37678910) (← links)
- Barrett's esophagus: Clinical issues. (Q37812916) (← links)
- Effects of environment and lifestyle on gastroesophageal reflux disease (Q37898419) (← links)